Target intelligence / Profile preview

Novel transcript, antisense to BOC

Molecular classification
Other (long noncoding RNA, antisense RNA)
01

Overview

ENSG00000288079 represents a **putative long noncoding RNA (antisense to the BOC locus)**. Antisense transcripts are RNA molecules transcribed from the DNA strand opposite to a protein-coding gene (in this case, BOC), often overlapping with parts of the sense gene[2][3][5]. Such RNAs can regulate gene expression at transcriptional, post-transcriptional, or epigenetic levels via mechanisms that include transcriptional interference, chromatin remodeling, RNA masking, miRNA regulation, and generation of endogenous siRNAs[2][3][1]. However, **the specific function and biological relevance of "novel transcript, antisense to BOC" remain uncharacterized**, and there are no known therapeutic interventions or disease associations directly linked to this transcript. Antisense lncRNAs are widely found in the genome, but only a few have established biological roles or therapeutic relevance[2][4]. Thus, **"novel transcript, antisense to BOC" is not a standard therapeutic target, and its presence in datasets primarily represents a genomic annotation rather than a confirmed molecular entity with known function or relevance in disease or drug action**[2][3][4][5]. - According to current research, antisense transcription can influence the expression of the protein-coding counterpart and modulate chromatin structure, but direct evidence for function at this specific locus is lacking[1][2][3]. - This entry is likely only a predicted, computationally annotated transcript without experimental validation or established relevance, so it does **not meet criteria for a canonical therapeutic target**. In summary: ENSG00000288079, or "novel transcript, antisense to BOC," is a provisionally annotated antisense long noncoding RNA gene without known function, molecular activity, or druggability, and is not a standard drug target. Its main distinguishing feature is its antisense orientation to the BOC gene; otherwise, it is not a canonical biological entity for therapeutic targeting.

Other names
ENSG00000288079
02

Biological functions

Other (putative regulatory ncRNA, function uncharacterized)
03

Disease associations

Other (no direct disease association reported)

Beyond the preview

Go deeper on Novel transcript, antisense to BOC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to BOC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call